阿庫拉製藥公司
US ˙ OTCPK

簡介

本頁面提供了有關 Galen Management, LLC 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Galen Management, LLC已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:QTNT / Quotient Ltd 10% Owner 0
US:ACUR / Acura Pharmaceuticals, Inc. 0
US:TCMD / Tactile Systems Technology, Inc. 10% Owner 907,736
如何解讀這些圖表

以下圖表顯示了在Galen Management, LLC進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

ACUR / Acura Pharmaceuticals, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 ACUR / Acura Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

ACUR / Acura Pharmaceuticals, Inc. Insider Trades
ACUR / Acura Pharmaceuticals, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 ACUR / Acura Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2017-12-14 ACUR CLAUDIUS LLC 2,195,734 0.1000 2,195,734 0.1000 219,573 270 0.1011 2,416 1.10
2015-06-17 ACUR CLAUDIUS LLC 3,900 1.0500 780 5.2500 4,095
2015-06-16 ACUR CLAUDIUS LLC 100,923 1.0844 20,185 5.4220 109,441
2015-01-12 ACUR CLAUDIUS LLC 35,000 0.6416 7,000 3.2080 22,456
2015-01-12 ACUR CLAUDIUS LLC 35,000 0.6416 7,000 3.2080 22,456
2015-01-09 ACUR CLAUDIUS LLC 36,000 0.6510 7,200 3.2550 23,436
2015-01-09 ACUR CLAUDIUS LLC 36,000 0.6510 7,200 3.2550 23,436
2015-01-08 ACUR CLAUDIUS LLC 100,000 0.6018 20,000 3.0090 60,180
2015-01-08 ACUR CLAUDIUS LLC 100,000 0.6018 20,000 3.0090 60,180
2014-03-03 ACUR CLAUDIUS LLC 2,500 2.0000 500 10.0000 5,000
2014-02-28 ACUR CLAUDIUS LLC 147,480 2.0054 29,496 10.0270 295,756
2014-02-28 ACUR CLAUDIUS LLC 21,602 2.0054 4,320 10.0270 43,321
2014-02-27 ACUR CLAUDIUS LLC 192,479 2.0415 38,496 10.2075 392,946
2014-02-26 ACUR CLAUDIUS LLC 6,301 1.9512 1,260 9.7560 12,295
2014-02-26 ACUR CLAUDIUS LLC 5,000 1.9545 1,000 9.7725 9,772
2014-02-24 ACUR CLAUDIUS LLC 43,747 1.9664 8,749 9.8320 86,024
2014-02-21 ACUR CLAUDIUS LLC 272 1.9500 54 9.7500 530
2014-02-18 ACUR CLAUDIUS LLC 2,200 1.9500 440 9.7500 4,290
2013-10-10 ACUR CLAUDIUS LLC 4,200 2.0500 840 10.2500 8,610
2013-07-02 ACUR CLAUDIUS LLC 200,000 2.1500 40,000 10.7500 430,000
2013-06-17 ACUR CLAUDIUS LLC 20,446 2.1500 4,089 10.7500 43,959
2013-06-14 ACUR CLAUDIUS LLC 27,814 2.1500 5,563 10.7500 59,800
2013-06-12 ACUR CLAUDIUS LLC 3,469 2.2000 694 11.0000 7,632
2013-06-10 ACUR CLAUDIUS LLC 9,700 2.2100 1,940 11.0500 21,437
2013-06-07 ACUR CLAUDIUS LLC 11,796 2.1900 2,359 10.9500 25,833
2013-06-06 ACUR CLAUDIUS LLC 10,001 2.1300 2,000 10.6500 21,302
2013-06-05 ACUR CLAUDIUS LLC 6,650 2.2100 1,330 11.0500 14,696
2013-06-04 ACUR CLAUDIUS LLC 22,802 2.2100 4,560 11.0500 50,392
2013-05-31 ACUR CLAUDIUS LLC 18,699 2.2500 3,740 11.2500 42,073
2013-05-30 ACUR CLAUDIUS LLC 12,860 2.2560 2,572 11.2800 29,012
2013-05-21 ACUR CLAUDIUS LLC 47,410 2.2986 9,482 11.4930 108,977
2013-05-20 ACUR CLAUDIUS LLC 68,993 2.3949 13,799 11.9745 165,231
2013-05-17 ACUR CLAUDIUS LLC 54,460 2.3557 10,892 11.7785 128,291
2013-05-16 ACUR CLAUDIUS LLC 42,599 2.2088 8,520 11.0440 94,093
2013-05-15 ACUR CLAUDIUS LLC 23,585 2.2729 4,717 11.3645 53,606
2013-05-14 ACUR CLAUDIUS LLC 87,399 2.4397 17,480 12.1985 213,227
2013-05-13 ACUR CLAUDIUS LLC 72,450 2.2092 14,490 11.0460 160,057
2013-05-07 ACUR CLAUDIUS LLC 20,887 2.2335 4,177 11.1675 46,651
2013-05-06 ACUR CLAUDIUS LLC 105,300 2.1234 21,060 10.6170 223,594
2013-05-03 ACUR CLAUDIUS LLC 27,117 2.2587 5,423 11.2935 61,249
2013-05-02 ACUR CLAUDIUS LLC 49,937 2.4700 9,987 12.3500 123,344
2013-05-01 ACUR CLAUDIUS LLC 106,027 2.3739 21,205 11.8695 251,697
2013-04-30 ACUR CLAUDIUS LLC 18,794 2.4783 3,759 12.3915 46,577
2013-04-29 ACUR CLAUDIUS LLC 13,642 2.5582 2,728 12.7910 34,899
2013-04-26 ACUR CLAUDIUS LLC 26,000 2.5547 5,200 12.7735 66,422
2013-04-25 ACUR CLAUDIUS LLC 16,700 2.6676 3,340 13.3380 44,549
2013-04-17 ACUR CLAUDIUS LLC 238,756 3.2045 47,751 16.0225 765,094
2013-04-16 ACUR CLAUDIUS LLC 21,800 2.1071 4,360 10.5355 45,935
2013-04-15 ACUR CLAUDIUS LLC 4,303 2.0967 861 10.4835 9,022
2013-04-12 ACUR CLAUDIUS LLC 13,200 2.2214 2,640 11.1070 29,322
2013-04-11 ACUR CLAUDIUS LLC 96,336 2.2422 19,267 11.2110 216,005
2013-04-10 ACUR CLAUDIUS LLC 25,118 2.1648 5,024 10.8240 54,375
2013-04-09 ACUR CLAUDIUS LLC 20,000 2.1400 4,000 10.7000 42,800
2013-04-08 ACUR CLAUDIUS LLC 80,554 2.1576 16,111 10.7880 173,803
2013-04-05 ACUR CLAUDIUS LLC 99,933 2.1569 19,987 10.7845 215,545

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

ACUR / Acura Pharmaceuticals, Inc. Insider Trades
TCMD / Tactile Systems Technology, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 ACUR / Acura Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

TCMD / Tactile Systems Technology, Inc. Insider Trades
TCMD / Tactile Systems Technology, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 ACUR / Acura Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2017-09-15 TCMD Galen Partners V LP 2,794,500 31.0200 2,794,500 31.0200 86,685,390 54 24.45 -18,359,865 -21.18
2017-06-28 TCMD Galen Partners V LP 200,000 28.8500 200,000 28.8500 5,770,000
2017-06-21 TCMD Galen Partners V LP 83,000 26.4500 83,000 26.4500 2,195,350
2017-06-13 TCMD Galen Partners V LP 295,455 25.0000 295,455 25.0000 7,386,375
2017-06-01 TCMD Galen Partners V LP 200,000 25.0000 200,000 25.0000 5,000,000
2017-05-11 TCMD Galen Partners V LP 325,000 21.2500 325,000 21.2500 6,906,250

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

TCMD / Tactile Systems Technology, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Galen Management, LLC 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2018-07-25 2018-07-23 4 QTNT Quotient Ltd
Warrant (Right to Buy)
X - Other -419,728 0 -100.00
2018-07-25 2018-07-23 4 QTNT Quotient Ltd
Ordinary Shares
X - Other 419,728 7,329,074 6.07 5.80 2,434,422 42,508,629
2018-01-02 2017-12-14 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -2,195,734 0 -100.00 0.10 -219,573
2017-10-30 2017-10-26 4 QTNT Quotient Ltd
Warrants to purchase Ordinary Shares
A - Award 419,728 419,728 0.12 52,466 52,466
2017-10-30 2017-10-26 4 QTNT Quotient Ltd
Ordinary Shares
A - Award 419,728 6,909,346 6.47 4.64 1,947,538 32,059,365
2017-09-19 2017-09-15 4 TCMD TACTILE SYSTEMS TECHNOLOGY INC
Common Stock
S - Sale -2,794,500 907,736 -75.48 31.02 -86,685,390 28,157,971
2017-06-29 2017-06-28 4 TCMD TACTILE SYSTEMS TECHNOLOGY INC
Common Stock
S - Sale -200,000 3,702,233 -5.13 28.85 -5,770,000 106,809,422
2017-06-22 2017-06-21 4 TCMD TACTILE SYSTEMS TECHNOLOGY INC
Common Stock
S - Sale -83,000 3,902,233 -2.08 26.45 -2,195,350 103,214,063
2017-06-14 2017-06-13 4 TCMD TACTILE SYSTEMS TECHNOLOGY INC
Common Stock
S - Sale -295,455 3,985,233 -6.90 25.00 -7,386,375 99,630,825
2017-06-02 2017-06-01 4 TCMD TACTILE SYSTEMS TECHNOLOGY INC
Common Stock
S - Sale -200,000 4,280,688 -4.46 25.00 -5,000,000 107,017,200
2017-05-16 2017-05-11 4/A TCMD TACTILE SYSTEMS TECHNOLOGY INC
Common Stock
S - Sale -325,000 4,480,688 -6.76 21.25 -6,906,250 95,214,620
2017-05-15 2017-05-11 4 TCMD TACTILE SYSTEMS TECHNOLOGY INC
Common Stock
S - Sale 325,000 4,480,688 7.82 21.25 6,906,250 95,214,620
2016-08-05 2016-08-03 4 QTNT Quotient Ltd
Ordinary Shares
P - Purchase 180,000 6,489,618 2.85 5.50 990,000 35,692,899
2016-08-04 2016-08-02 4 TCMD TACTILE SYSTEMS TECHNOLOGY INC
Series B Preferred Stock
C - Conversion -1,156,467 0 -100.00
2016-08-04 2016-08-02 4 TCMD TACTILE SYSTEMS TECHNOLOGY INC
Series A Preferred Stock
C - Conversion -1,942,336 0 -100.00
2016-08-04 2016-08-02 4 TCMD TACTILE SYSTEMS TECHNOLOGY INC
Common Stock
C - Conversion 2,001,296 4,743,633 72.98
2016-08-04 2016-08-02 4 TCMD TACTILE SYSTEMS TECHNOLOGY INC
Common Stock
C - Conversion 2,742,337 2,742,337
2016-07-27 3 TCMD TACTILE SYSTEMS TECHNOLOGY INC
Common Stock
124,110
2016-07-27 3 TCMD TACTILE SYSTEMS TECHNOLOGY INC
Common Stock
124,110
2016-07-27 3 TCMD TACTILE SYSTEMS TECHNOLOGY INC
Common Stock
124,110
2016-07-27 3 TCMD TACTILE SYSTEMS TECHNOLOGY INC
Common Stock
124,110
2016-07-27 3 TCMD TACTILE SYSTEMS TECHNOLOGY INC
Common Stock
124,110
2016-02-12 2016-02-10 4 QTNT Quotient Ltd
Ordinary Shares
P - Purchase 222,222 6,309,618 3.65 9.00 1,999,998 56,786,562
2015-09-22 2015-09-18 4 QTNT Quotient Ltd
Warrant (Right to Buy)
X - Other -312,500 0 -100.00
2015-09-22 2015-09-18 4 QTNT Quotient Ltd
Ordinary Shares
X - Other 249,999 6,087,396 4.28 8.80 2,199,991 53,569,085
2015-06-18 2015-06-17 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -3,900 10,978,674 -0.04 1.05 -4,095 11,527,608
2015-06-18 2015-06-16 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -100,923 10,982,574 -0.91 1.08 -109,441 11,909,503
2015-01-26 2015-01-12 4/A ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -35,000 11,083,497 -0.31 0.64 -22,456 7,111,172
2015-01-26 2015-01-09 4/A ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -36,000 11,118,497 -0.32 0.65 -23,436 7,238,142
2015-01-26 2015-01-08 4/A ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -100,000 11,154,497 -0.89 0.60 -60,180 6,712,776
2015-01-12 2015-01-12 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -35,000 10,957,621 -0.32 0.64 -22,456 7,030,410
2015-01-12 2015-01-09 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -36,000 10,992,621 -0.33 0.65 -23,436 7,156,196
2015-01-12 2015-01-08 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -100,000 11,028,621 -0.90 0.60 -60,180 6,637,024
2014-12-01 2014-11-28 4 QTNT Quotient Ltd
Ordinary Shares
P - Purchase 157,895 5,837,397 2.78 9.50 1,500,002 55,455,272
2014-05-01 2014-04-30 4 QTNT Quotient Ltd
Warrant to Purchase Ordinary Shares (right to buy)
P - Purchase 312,500 312,500
2014-05-01 2014-04-30 4 QTNT Quotient Ltd
Ordinary Shares
P - Purchase 312,500 5,679,502 5.82 8.00 2,500,000 45,436,016
2014-04-24 3 QTNT Quotient Ltd
Ordinary shares
10,734,004
2014-04-24 3 QTNT Quotient Ltd
Ordinary shares
10,734,004
2014-04-24 3 QTNT Quotient Ltd
Ordinary shares
10,734,004
2014-04-24 3 QTNT Quotient Ltd
Ordinary shares
10,734,004
2014-04-24 3 QTNT Quotient Ltd
Ordinary shares
10,734,004
2014-03-24 2014-02-28 4/A ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -21,602 11,256,998 -0.19 2.01 -43,321 22,574,784
2014-03-05 2014-03-03 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -2,500 11,128,618 -0.02 2.00 -5,000 22,257,236
2014-02-28 2014-02-28 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -147,480 11,131,118 -1.31 2.01 -295,756 22,322,344
2014-02-28 2014-02-27 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -192,479 11,278,598 -1.68 2.04 -392,946 23,025,258
2014-02-28 2014-02-26 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -5,000 11,471,078 -0.04 1.95 -9,772 22,420,222
2014-02-28 2014-02-26 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -6,301 11,476,078 -0.05 1.95 -12,295 22,392,123
2014-02-25 2014-02-24 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -43,747 11,482,379 -0.38 1.97 -86,024 22,578,950
2014-02-25 2014-02-21 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -272 11,526,126 0.00 1.95 -530 22,475,946
2014-02-20 2014-02-18 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -2,200 11,526,398 -0.02 1.95 -4,290 22,476,476
2013-10-11 2013-10-10 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -4,200 11,528,598 -0.04 2.05 -8,610 23,633,626
2013-07-03 2013-07-02 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -200,000 11,532,798 -1.70 2.15 -430,000 24,795,516
2013-06-19 2013-06-17 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -20,446 11,732,798 -0.17 2.15 -43,959 25,225,516
2013-06-14 2013-06-14 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -27,814 11,753,244 -0.24 2.15 -59,800 25,269,475
2013-06-14 2013-06-12 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -3,469 11,781,058 -0.03 2.20 -7,632 25,918,328
2013-06-11 2013-06-10 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -9,700 11,784,527 -0.08 2.21 -21,437 26,043,805
2013-06-11 2013-06-07 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -11,796 11,794,227 -0.10 2.19 -25,833 25,829,357
2013-06-07 2013-06-06 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -10,001 11,806,023 -0.08 2.13 -21,302 25,146,829
2013-06-07 2013-06-05 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -6,650 11,816,024 -0.06 2.21 -14,696 26,113,413
2013-06-07 2013-06-04 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -22,802 11,822,674 -0.19 2.21 -50,392 26,128,110
2013-06-03 2013-05-31 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -18,699 11,845,476 -0.16 2.25 -42,073 26,652,321
2013-06-03 2013-05-30 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -12,860 11,864,175 -0.11 2.26 -29,012 26,765,579
2013-05-23 2013-05-21 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -47,410 11,877,035 -0.40 2.30 -108,977 27,300,553
2013-05-20 2013-05-20 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -68,993 11,924,445 -0.58 2.39 -165,231 28,557,853
2013-05-20 2013-05-17 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -54,460 11,993,438 -0.45 2.36 -128,291 28,252,942
2013-05-20 2013-05-16 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -42,599 12,047,898 -0.35 2.21 -94,093 26,611,397
2013-05-15 2013-05-15 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -23,585 12,090,497 -0.19 2.27 -53,606 27,480,491
2013-05-15 2013-05-14 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -87,399 12,114,082 -0.72 2.44 -213,227 29,554,726
2013-05-15 2013-05-13 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -72,450 12,201,481 -0.59 2.21 -160,057 26,955,512
2013-05-07 2013-05-07 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -20,887 12,334,527 -0.17 2.23 -46,651 27,549,166
2013-05-07 2013-05-06 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -105,300 12,355,414 -0.85 2.12 -223,594 26,235,486
2013-05-07 2013-05-03 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -27,117 12,460,714 -0.22 2.26 -61,249 28,145,015
2013-05-02 2013-05-02 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -49,937 12,487,831 -0.40 2.47 -123,344 30,844,943
2013-05-02 2013-05-01 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -106,027 12,537,768 -0.84 2.37 -251,697 29,763,407
2013-05-02 2013-04-30 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -18,794 12,643,795 -0.15 2.48 -46,577 31,335,117
2013-04-29 2013-04-29 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -13,642 12,662,589 -0.11 2.56 -34,899 32,393,435
2013-04-29 2013-04-26 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -26,000 12,676,231 -0.20 2.55 -66,422 32,383,967
2013-04-29 2013-04-25 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -16,700 12,702,231 -0.13 2.67 -44,549 33,884,471
2013-04-19 2013-04-17 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -238,756 12,718,931 -1.84 3.20 -765,094 40,757,814
2013-04-16 2013-04-16 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -21,800 12,957,687 -0.17 2.11 -45,935 27,303,142
2013-04-16 2013-04-15 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -4,303 12,979,487 -0.03 2.10 -9,022 27,214,090
2013-04-16 2013-04-12 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -13,200 12,983,790 -0.10 2.22 -29,322 28,842,191
2013-04-11 2013-04-11 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -96,336 12,996,990 -0.74 2.24 -216,005 29,141,851
2013-04-11 2013-04-10 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -25,118 13,093,326 -0.19 2.16 -54,375 28,344,432
2013-04-09 2013-04-09 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -20,000 13,118,444 -0.15 2.14 -42,800 28,073,470
2013-04-09 2013-04-08 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -80,554 13,138,444 -0.61 2.16 -173,803 28,347,507
2013-04-09 2013-04-05 4 ACUR ACURA PHARMACEUTICALS, INC
Common Stock
S - Sale -99,933 13,218,998 -0.75 2.16 -215,545 28,512,057
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)